Interrogating which pathways downstream of PPARδ are activated in distinct settings/CRC subtypes, and distinguishing which PPARδ coactivator/corepressor interacting partners are recruited to its homeostatic roles in normal ISC physiology, and which can impact oncogenesis, may yield valuable therapeutic insights. Here, PPARD is linked to colorectal carcinoma.